Showing results (211-220 of 291) with videos related to

Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 25, 2004
Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patientsM E Jones, J A Karlowsky, D C Draghi, et al.
The Journal of Infectious Diseases|February 1, 1978
Penicillinase-producing Neisseria gonorrhoeae: results of surveillance in the United StatesM S Siegel, C Thornsberry, J W Biddle, et al.
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|November 11, 1991
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test mediumG V Doern, E H Gerlach, J H Jorgensen, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.
The New England Journal of Medicine|January 1, 1976
National gonorrhea therapy monitoring study: treatment resultsR E Kaufman, R E Johnson, H W Jaffe, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Pageof 30